UK markets close in 45 minutes

Spero Therapeutics, Inc. (SPRO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.7724-0.0084 (-1.08%)
As of 10:45AM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
No. of analysts4455
Avg. Estimate-0.89-0.54-2.79-1.84
Low estimate-1.02-0.72-3.34-2.82
High estimate-0.8-0.25-2.17-1.18
Year ago EPS-0.63-0.7-2.91-2.79
Revenue estimateCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
No. of analysts3332
Avg. Estimate1.77M2.01M7.71M5.8M
Low estimateN/AN/A2.1MN/A
High estimate3M3.7M12M11.6M
Year ago sales5.15MN/A18.26M7.71M
Sales growth (year/est)-65.60%N/A-57.80%-24.80%
Earnings history29/06/202129/09/202130/12/202130/03/2022
Est. EPS-0.75-0.66-0.75-0.87
Actual EPS-0.63-0.7-0.9-1.01
Difference0.12-0.04-0.15-0.14
Surprise %16.00%-6.10%-20.00%-16.10%
EPS trendCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
Current estimate-0.89-0.54-2.79-1.84
7 days ago-0.89-0.54-2.79-1.84
30 days ago-0.85-0.49-2.6-1.71
60 days ago-0.75-0.69-3.06-2.02
90 days ago-0.93-0.93-3.46-1.68
EPS revisionsCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
Up last 7 daysN/AN/A1N/A
Up last 30 daysN/AN/A1N/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesSPROIndustrySector(s)S&P 500
Current qtr.-41.30%N/AN/AN/A
Next qtr.22.90%N/AN/AN/A
Current year4.10%N/AN/AN/A
Next year34.10%N/AN/AN/A
Next 5 years (per annum)36.90%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A